Vergleich

SYNAPTOPHYSIN

ArtNr 20-783-70322
Hersteller GENWAY
Menge 0.02 mg
Kategorie
Typ Antibody
Applikationen IHC
Clon SP15
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-CC989C
Similar products 20-783-70322
Lieferbar
Genway ID:
GWB-CC989C
Specificity:
SYNAPTOPHYSINNCBI
Gene ID:
6855
Specificity:
SYNAPTOPHYSIN
Clone:
SP15
Immunogen:
Crude human synaptic immunoprecipitate
Fusion Partner:
Spleen cells from immunised BALB/c mice were fused with cells of the NSO mouse myeloma cell line.
Specificity Note:
This product recognises an antigen which appears to be identical to the human synaptic vesicle protein synaptophysin. It reacts with synaptophysin expressed in CHO cells (3. 8. ). Histology: Pancreas
Preparation:
Purified IgM prepared by gel filtration from tissue culture supernatant
Buffer Solution:
Phosphate buffered saline pH7. 2
Preservative Stabilisers:
0. 09%Sodium AzideSuggested
Dilution:
Suggested
Dilution:
Immunohistology - Paraffin - 1/25
Function:
Possibly involved in structural functions as organizing other membrane components or in targeting the vesicles to the plasma membrane.
Subunit:
Homohexamer or homotetramer.
Subcellular Location:
Cytoplasmic vesicle secretory vesicle synaptic vesicle membrane; Multi-pass membrane protein. Cell junction synapse synaptosome.
Tissue Specificity:
Characteristic of a type of small (30-80 nm) neurosecretory vesicles including presynaptic vesicles but also vesicles of various neuroendocrine cells of both neuronal and epithelial phenotype.
Domain:
The calcium-binding activity is thought to be localized in the cytoplasmic tail of the protein.
Ptm:
Ubiquitinated; mediated by SIAH1 or SIAH2 and leading to its subsequent proteasomal degradation (By similarity).
Similarity:
Belongs to the synaptophysin/synaptobrevin family.
Similarity:
Contains 1 MARVEL domain. 1. Honer. W. G. et al. (1994) Hippocampal synaptic pathology in patients with temporal lobe epilepsy. 2. Honer. W. G. et al. (1992) Regional synaptic pathology in Alzheimer\' s disease. 3. Honer. W. G. et al. (1993) Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex. 4. Honer. W. G. et al. (1992) Characterization of a synaptic antigen of interest in neuropsychiatric illness. 5. Honer. W. G. et al. (1989) Monoclonal antibodies to study the brain in schizophrenia. 6. Masliah. E. et al. (1994) Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer\' s disease hippocampus. 7. Simpson. I. A. et al. (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\' s disease. 8. Wakabayashi. K. et al. (1994) Synapse alterations in the hippocampalentorhinal formation in Alzheimer\' s disease with and without Lewy body disease. 9. Dickson. D. W. et al. (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (> 80 years of age) humans. Acta Neuropathologica 88: 212-221. 10. Dickson. D. W. et al. (1995) Correlations of synaptic and pathological markers with cognition of the elderly. 11. Dickson. D. W. et al. (1995) Correlations of synaptic markers with cognitive status in prospectively studied elderly humans. Neurobiol Aging 16:285-98.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.02 mg
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 11.09.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen